Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: Data from ROCKET AF

Keyphrases

• Adjusted Dose 20%
• All-cause Mortality 100%
• Antagonism 20%
• Anticoagulated 20%
• Anticoagulated Patients 100%
• Atrial Fibrillation 40%
• Backward Elimination 20%
• C-index 20%
• Cause of Death 100%
• CHADS2 Score 20%
• Chronic Obstructive Pulmonary Disease 40%
• Cox Proportional Hazards Regression 20%
• Creatinine Clearance 20%
• Diabetes 40%
• Direct Factors 20%
• Embolism 20%
• Factor Xa Inhibitors 20%
• Failure Hazard 20%
• Hazard Ratio 40%
• Heart Failure 20%
• Heart Failure Therapy 20%
• Hemorrhagic Stroke 40%
• High Mortality 40%
• Kaplan-Meier 20%
• Large Population 20%
• Male Sex 20%
• Mortality Rate 20%
• No Significant Difference 20%
• Once-daily 20%
• Paroxysmal Atrial Fibrillation 100%
• Peripheral Vascular Disease 20%
• Renal Impairment 20%
• Risk Factors 20%
• Rivaroxaban 60%
• ROCKET-AF 100%
• Stroke Prevention 20%
• Systemic Embolism 40%
• Vitamin K 20%
• Warfarin 40%

Medicine and Dentistry

• All Cause Mortality 100%
• Apoplexy 60%
• Arm 20%
• Atrial Fibrillation 100%
• Cardiovascular System 40%
• CHADS2 Score 20%
• Chronic Obstructive Pulmonary Disease 40%
• Congestive Heart Failure 40%
• Creatinine Clearance 20%
• Diabetes 40%
• Embolism 60%
• Hazard Ratio 40%
• Median Follow Up 20%
• Mortality Rate 20%
• Oral 20%
• Peripheral Vascular Disease 20%
• Proportional Hazards Model 20%
• Prothrombinase 20%
• Rivaroxaban 60%
• Warfarin 40%

Pharmacology, Toxicology and Pharmaceutical Science

• All Cause Mortality 100%
• Atrial Fibrillation 100%
• Blood Clotting Factor 10a 20%
• Cerebrovascular Accident 60%
• Chronic Obstructive Lung Disease 40%
• Congestive Heart Failure 40%
• Creatinine 20%
• Elimination 20%
• Embolism 60%
• Mortality Rate 20%
• Peripheral Vascular Disease 20%
• Rivaroxaban 60%
• Vitamin K Group 20%
• Warfarin 40%